Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer – Day 2

Welcome to Day Two of the Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer!

Building on the momentum of Day One, today’s sessions bring together doctors, advocates, and thought leaders to explore innovative approaches, address pressing challenges, and foster collaboration. From groundbreaking research to inspiring initiatives, we continue to push boundaries and shape the future of colorectal cancer care.

Let’s move forward together!

Professor Daiming Fan, President of the China Anti-Cancer Association, inaugurated Day Two of the conference with an inspiring keynote, highlighting opportunities in colorectal cancer research and recognizing the significance of the Global Cancer Movement.

Is ctDNA better than disease stage?

Professor Julien Taieb showcased latest findings on ctDNA, exploring whether it serves as a superior prognostic tool compared to traditional disease staging.

Alma Zhylkaidarova discussed Kazakhstan’s colorectal cancer screening program, shedding light on the process, challenges, and the critical role of early detection in improving outcomes and Abay Jumanov highlighted colorectal cancer as the third leading cause of cancer-related deaths in Kazakhstan, addressing the need for intensified awareness and intervention efforts.

Dr. Amil Družić presented the efficacy of the Watch-and-Wait Approach and organ preservation strategies in LARC patients who achieved complete clinical responses after TNT.

Dr. Amalya Sargsyan, Head of the Intelligence Unit at OncoDaily, outlined strategies for fostering inclusivity and diversity in cancer clinical trials, emphasizing the contributions of small populations to global cancer research.

Dr. Verna Vanderpuye addressed the alarming rate of burnout and depression among female physicians, emphasizing the unique challenges faced by women oncologists.

“Female physicians are twice as likely to experience burnout and depression compared to male”.

Dr. Sabine Tejpar explored the limitations of the traditional oncogene model and shared insights on innovative therapeutic targets in colorectal cancer treatment.

“This isn’t a presentation—it’s a conversation. Instead of a traditional talk, this session listens to a dialogue between a young advocate and a health minister, highlighting the transformative role of youth in cancer prevention and control” – Christos Tsagkaris, Youth Ambassador for the European Code Against Cancer.

Dr. Johanna Rapanarilala presented the unique challenges encountered by oncologists in Seychelles, offering a rare perspective on delivering cancer care in small island nations.

Dr. Malar Velli Segarmurthy addressed the stark disparity in global opioid consumption, emphasizing that only 9% of the world’s supply is utilized in LMICs, leaving patients in these regions with limited access to pain relief and palliative care.

Dr. Amina Suleymanova delivered an in-depth presentation on “Colorectal Cancer in Pediatric Patients: A Rare and Critical Concern,” featuring a compelling clinical case study.

George Kapetanakis concluded his speech with a powerful and timeless quote: “When ‘I’ is replaced with ‘WE,’ even ‘Illness’ becomes ‘Wellness.'”

Prof. Manish Shah presented the American Society of Clinical Oncology (ASCO)’s Strategic Plan for the Management of Colorectal Cancer, offering a comprehensive overview during the Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer.

Dr. Christine Parseghian delivered an insightful presentation on the mechanisms of resistance to EGFR-targeted therapies in colorectal cancer, focusing on factors beyond genetics.

Prof. Marwan Fakih explored the potential role of metastatic site location in explaining variations in CPI response among MSS CRC patients, contributing to the ongoing discussions during the Global Cancer Movement.

“Seven in ten people report emotional concerns, including fear of recurrence.”

Adrian Pogacian addressed this at the Global Cancer Movement, highlighting the emotional toll of the cancer journey.

Colorectal Cancer with Liver Metastasis — How Can We Increase the Chances of Cure: Prof. Piotr J. Wysocki closed Day 2 of the Global Cancer Movement with insightful data and key takeaways.

To learn more and register follow the link.